Zimmer Biomet expands ROSA ONE portfolio with FDA clearance for use in spine surgeries

Zimmer Biomet said Monday that the ROSA ONE Spine system for robotically assisted, minimally invasive and complex spine surgeries gained FDA 510(k) clearance. Aure Bruneau, group president of spine, craniomaxillofacial, thoracic and surgery assisting technologies at the company, noted that "ROSA ONE Spine functions as a dual robotics and navigation technology solution for minimally invasive and complex thoracolumbar spine procedures."

According to Zimmer Biomet, the ROSA ONE Spine system delivers a "unique real-time patient 'dynamic tracking' capability," and also features 3D intraoperative planning software along with a navigation suite of technologies designed to improve implant and instrument placement accuracy and predictability.

Zimmer Biomet noted that ROSA ONE Spine is available on the same platform as the ROSA ONE Brain and ROSA Knee systems, which both gained FDA clearance earlier this year, "providing the only robot hardware platform on the market to treat neurosurgical, spinal and knee pathologies."

The company gained the ROSA ONE Spine and ROSA ONE Brain systems through its acquisition of surgical robotics provider Medtech in 2016.

Did you like this article?